Viewing Study NCT06378866


Ignite Creation Date: 2025-12-24 @ 4:21 PM
Ignite Modification Date: 2025-12-28 @ 4:40 AM
Study NCT ID: NCT06378866
Status: RECRUITING
Last Update Posted: 2025-10-16
First Post: 2024-04-16
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Stereotactic Body Radiation Therapy Plus Androgen Receptor Pathway Inhibitor and Androgen Deprivation Therapy for Treatment of Metastatic, Recurrent Hormone-Sensitive Prostate Cancer, DIVINE Trial
Sponsor: Mayo Clinic
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module